Follow-on biologic drug competition – No need for new marketing exclusivities

ISSN： 1478-565X

Source： Journal of Commercial Biotechnology, Vol.16, Iss.1, 2010-01, pp. : 5-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Leishmaniasis: History, Evolution of Treatment and the Need for New Drugs

Current Biotechnology, Vol. 3, Iss. 4, 2014-11 ,pp. : 279-288

Bentham Science Publishers

Access to resources Recommend Favorite

New biopharmaceuticals in the USA: trends in development and marketing approvals 1995-1999

By Reichert J.M.

Trends in Biotechnology, Vol. 18, Iss. 9, 2000-09 ,pp. : 364-369

Elsevier

Access to resources Recommend Favorite

Fluorescent-protein biosensors: new tools for drug discovery

By Giuliano K.A. Taylor D.L.

Trends in Biotechnology, Vol. 16, Iss. 3, 1998-03 ,pp. : 135-140

Elsevier

Access to resources Recommend Favorite

A new science-business paradigm in anticancer drug development

By Blagosklonny M.V.

Trends in Biotechnology, Vol. 21, Iss. 3, 2003-03 ,pp. : 103-106

Elsevier

Access to resources Recommend Favorite

Biotechnologies in new high-throughput food allergy tests: why we need them

By Renault Neil Mirotti Luciana Alcocer Marcos

Biotechnology Letters, Vol. 29, Iss. 3, 2007-03 ,pp. : 333-339

Springer Publishing Company

Access to resources Recommend Favorite